Status:
UNKNOWN
Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases
Lead Sponsor:
Laval University
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluation of diagnostic yield, feasibility and safety of transbronchial lung cryobiopsies done via bronchoscopy in the investigation of interstitial lung disease in comparison with videothoracoscopy-...
Detailed Description
See above
Eligibility Criteria
Inclusion
- Volunteer subjects with interstitial lung disease in whom a surgical lung biopsy is planned for diagnostic investigation.
Exclusion
- Aged less than 18 y.o.
- Pregnancy
- Known coagulatoin disorder or blood dyscrasia
- Aaking antiplatelet agents other than aspirin or therapeutic anticoagulants drugs that cannot be safely discontinued to undergo lung biopsy
- Arterial oxgen pressure less than 60 mmHg on more than 2 liters per minute oxygen
- Known pulmonary hypertension defined as systolic PAP above 40 mmHg on echocardiography
- Unable to provide informed consent
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02235779
Start Date
August 1 2014
End Date
December 1 2021
Last Update
March 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Canada, G1V 4G5